HCV Treatment
PSI-7977 + BMS-790052 Trial for Hepatitis C
- Details
- Category: Experimental HCV Drugs
- Published on Friday, 03 June 2011 13:01
- Written by Pharmasset
Pharmasset announced the start of a Phase 2a study of an all-oral antiviral regimen of HCV polymerase inhibitor PSI-7977 plus NS5A replication complex inhibitor BMS-790052.
Telaprevir (Incivek) Patient Assistance Program
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 31 May 2011 13:59
- Written by Vertex Pharmaceuticals
Vertex Pharmaceuticals has started programs to help people with hepatitis C access its recently approved HCV drug telaprevir.
Telaprevir (Incivek) Approved for Hepatitis C
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 24 May 2011 14:19
- Written by Liz Highleyman
Boceprevir (Victrelis) Patient Assistance Program
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 31 May 2011 12:52
- Written by Merck
Merck has announced programs to help hepatitis C patients obtain its newly approved HCV protease inhibitor boceprevir.
European Committee Recommends Boceprevir (Victrelis)
- Details
- Category: Experimental HCV Drugs
- Published on Friday, 20 May 2011 14:35
- Written by Merck
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of the HCV protease inhibitor boceprevir (brand name Victrelis) for treatment of chronic hepatitis C.
Web Design and Development by